These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3067707)

  • 1. Immunosuppression after heart transplantation. Clinical results in three ciclosporin-based immunosuppressive protocols.
    Schüler S; Hetzer R
    Bibl Cardiol; 1988; (43):10-8. PubMed ID: 3067707
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of toxic side effects of cyclosporine in heart transplantation.
    Schüler S; Warnecke H; Hetzer R
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2518-21. PubMed ID: 3547936
    [No Abstract]   [Full Text] [Related]  

  • 3. Antithymocyte gamma globulin, low-dosage cyclosporine, and tapering steroids as an immunosuppressive regimen to avoid early kidney failure in heart transplantation.
    Deeb GM; Kolff J; McClurken JB; Dunn J; Balsara R; Ochs R; Badellino M; Hollander T; Eldridge C; Clancey M
    J Heart Transplant; 1987; 6(2):79-83. PubMed ID: 3305833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart transplantation: limitations and perspectives.
    Struck E; Hagl S; Meisner H; Sebening F
    Z Kardiol; 1985; 74 Suppl 6():59-63. PubMed ID: 3913181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac transplantation in children and adolescents.
    Starnes VA; Stinson EB; Oyer PE; Valantine H; Baldwin JC; Hunt SA; Shumway NE
    Circulation; 1987 Nov; 76(5 Pt 2):V43-7. PubMed ID: 3311454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Renal function in the immediate postoperative period after heart transplantation using very low initial doses of cyclosporin A].
    Cladellas M; Sánchez JM; Abadal ML; Ballester M; Obrador D; Amengual MJ; Quintana E; Net A; Cámara ML; Padró JM
    Rev Esp Cardiol; 1987; 40 Suppl 2():70-3. PubMed ID: 3331810
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term effects of cyclosporine-based immunosuppression in cardiac transplantation: the Loyola experience.
    Costanzo-Nordin MR; Grady KL; Johnson MR; Winters GL; Ventura HO; Pifarré R
    Transplant Proc; 1990 Jun; 22(3 Suppl 1):6-11. PubMed ID: 2349737
    [No Abstract]   [Full Text] [Related]  

  • 8. Avoidance of perioperative renal toxicity by a modified immunosuppression protocol.
    Kormos RL; Trento A; Hardesty RL; Griffith BP; Thompson M; Bahnson HT
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2525-6. PubMed ID: 3274555
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of low-dose cyclosporine A on toxicity and rejection in cardiac transplantation.
    Spratt P; Esmore D; Baron D; Shanahan MX; Farnsworth AE; Chang VP
    Transplant Proc; 1987 Apr; 19(2):2847-50. PubMed ID: 3551225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart transplantation in Paris, at "La Pitie" Hospital.
    Cabrol C; Gandjbakhch I; Pavie A; Cabrol A; Mattei MF; Leger P
    J Heart Transplant; 1985; 4(5):476-80. PubMed ID: 3916522
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term morbidity of cyclosporine with corticosteroid-free maintenance immunosuppression in cardiac transplantation.
    Moore CK; Bristow MR; Renlund DG; Rasmussen LG; O'Connell JB
    Transplant Proc; 1990 Jun; 22(3 Suppl 1):25-9. PubMed ID: 2349736
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical management of immunosuppressive therapy for cyclosporine-treated recipients of cadaver kidney transplants at one to six months.
    Feduska NJ; Melzer J; Amend WJ; Vincenti F; Tomlanovich S; Salvatierra O
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):136-40. PubMed ID: 3515681
    [No Abstract]   [Full Text] [Related]  

  • 13. [Heart transplantation].
    Hetzer R; Warnecke H; Schüler S; Süthoff U; Wonigeit K; Lang W; Herrmann G; Hepp A; Schaps D; Borst HG
    Internist (Berl); 1985 Sep; 26(9):563-8. PubMed ID: 3905678
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunosuppression after heart transplantation. Results of a study of 2 therapeutic protocols].
    Faggian G; Livi U; Chiominto B; Michielon G; Angelini A; Bortolotti U; Mazzucco A; Thiene G; Gallucci V
    G Ital Cardiol; 1989 Dec; 19(12):1141-3. PubMed ID: 2634570
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of three immunosuppressive protocols in cardiac transplantation.
    Spratt P; Esmore D; Keogh A; Chang V
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2481-3. PubMed ID: 2650309
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiac transplantation in France--current problems.
    Cabrol C; Gandjbakhch I; Pavie A; Bors V; Cabrol A; Leger P; Levasseur JP; Szefner J
    Transplant Proc; 1987 Aug; 19(4 Suppl 5):12-5. PubMed ID: 3303562
    [No Abstract]   [Full Text] [Related]  

  • 17. [Infections in the heart transplant patient treated with cyclosporin A].
    Gurguí M; Rabella N; Verger G; Abadal ML; Cladellas M; Obrador D; Ballester M
    Rev Esp Cardiol; 1987; 40 Suppl 2():84-8. PubMed ID: 3331813
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclosporine in heart and heart-lung transplantation.
    Modry DL; Oyer PE; Jamieson SW; Stinson EB; Baldwin JC; Reitz BA; Dawkins KD; McGregor CG; Hunt SA; Moran M
    Can J Surg; 1985 May; 28(3):274-80, 282. PubMed ID: 3922606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of cyclosporine on the practice of renal transplantation.
    Kahan BD
    Transplant Proc; 1989 Jun; 21(3 Suppl 1):63-9. PubMed ID: 2545019
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectiveness of minimal dosage cyclosporine in limiting toxicity and rejection.
    Spratt P; Esmore D; Baron D; Shanahan MX; Farnsworth AE; Chang VP
    J Heart Transplant; 1986; 5(1):8-12. PubMed ID: 3302158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.